Tuesday, April 07, 2026 | 01:20 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
SI Reporter

SI Reporter

SI Reporter

The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.

The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.

Si Reporter/undefined

Alembic Pharma gains 4% on getting USFDA nod for Dapagliflozin tablets

Dapagliflozin Tablets is a generic version of AstraZeneca's Farxiga, which had an estimated US market size of $10,487 million for the twelve months ending December 2025

Alembic Pharma gains 4% on getting USFDA nod for Dapagliflozin tablets
Updated On : 07 Apr 2026 | 1:06 PM IST

Globus Spirits shares jump 7% after launching CRT-certified TERAI Tequila

The buying on the counter came after Globus Spirit announced the launch of TERAI Tequila.

Globus Spirits shares jump 7% after launching CRT-certified TERAI Tequila
Updated On : 07 Apr 2026 | 12:30 PM IST